Sonic Healthcare Limited
ASX: SHL
Strong testing demand and margin gains drive Sonic Healthcare’s robust revenue growth.
(Source: TradingView) 3-Month Performance Profile of SHL on a DTF compared to S&P/ASX 200 (XJO).
Sonic Healthcare reported a 9.7% YoY rise in revenue to $9.5 billion for FY2025, supported by solid operational execution and expanding testing volumes. Operating cash flow c
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
